U.S., March 21 -- ClinicalTrials.gov registry received information related to the study (NCT07486115) titled 'A Study to Test How Different Doses of BI 3814916 Are Tolerated by Healthy People' on March 17.
Brief Summary: The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 3814916 in healthy male and female trial participants.
Study Start Date: April 07
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
BIOLOGICAL: BI 3814916
BI 3814916
DRUG: Placebo matching BI 3814916
Placebo matching BI 3814916
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Boehringer Ingelheim
Published by HT Digital Content Services with permission from Health Daily Digest....